ArticlePharmaceuticals (Basel, Switzerland)2025

PCSK9 Inhibitor and Potential Decreased Risk of Neoplasms, Especially in Females: A Meta-Analysis.

Tingyang Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.